Aptevo Therapeutics Inc. Income Taxes Receivable, Current
Aptevo Therapeutics Inc. (APVO) had Income Taxes Receivable, Current of $1.40 million as of 2016-06-30, per its 10-Q/A filed 2016-09-22.
Discontinued › Notes
us-gaap:IncomeTaxesReceivable · last filed 2017-03-31
- 2016-06-30: Income Taxes Receivable, Current $1.40M.
- 2015-12-31: Income Taxes Receivable, Current $1.38M.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2016-06-30 | $1.40M 10-Q/A · filed 2016-09-22 |
| 2015-12-31 | $1.38M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |